Subtype
Diffuse Glioma
CI-CAN-00002519Explore in graph →
Non-malignant787 active trials5 approved drugs147 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002519Explore in graph →
Clinical trials
2,804 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05536986 | Correlation Between Psychological Stress and Progression of Newly Oligodendroglioma Towards Secondary Glioma | not yet recruiting | — | 60 | Henan Provincial People's HospitalOTHER | 0 | Sep 27, 2022 | clinicaltrials |
| NCT05541042 | Radiogenomics in Glioblastoma: Correlation Between Multiparametric Imaging Biomarkers and Genetic Biomarkers | not yet recruiting | — | 50 | Henan Provincial People's HospitalOTHER | 1 | Sep 27, 2022 |
| clinicaltrials |
| NCT05263466 | Establishing Radiolabelled PSMA as a Target for Glioma Treatment | not yet recruiting | N/A | 30 | King's College Hospital NHS TrustOTHER | 1 | Jun 10, 2022 | clinicaltrials |
| NCT05140785 | Mapping Molecular Markers of Brain Tumour Activity Using MRI | not yet recruiting | N/A | 30 | King's College Hospital NHS TrustOTHER | 1 | Mar 9, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Sep 27, 2022source: clinicaltrials